戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ds (i.e. Se bonded to two carbon atoms, e.g. methylselenocysteine).
2 y of the selenoamino acids in the form of Se-methylselenocysteine.
3 esponse at one-tenth the concentration of Se-methylselenocysteine.
4 nocysteine and the targeted sequestration of methylselenocysteine.
5 toxifies selenocysteine by methylating it to methylselenocysteine, a nonprotein amino acid, thereby d
6 nium compounds - selenite, selenomethionine, methylselenocysteine and selenocystine - is presented, w
7 tizes HCT 116 cells to methylseleninic acid, methylselenocysteine, and sodium selenite via reactive o
8 of sodium selenite, methylseleninic acid and methylselenocysteine for 48 h, followed by a recovery of
9                            Gamma-glutamyl-Se-methylselenocysteine (GGMSC) has recently been identifie
10 methylseleninic acid was more potent than Se-methylselenocysteine in inhibiting cell accumulation and
11 hile selenomethionine, selenocystine, and Se-methylselenocysteine in pink oyster mushrooms.
12 ly and exerts a more powerful effect than Se-methylselenocysteine in vitro.
13 a monomethylated selenium metabolite from Se-methylselenocysteine is a key step in cancer chemopreven
14 umulation of S-methylcysteine (MeCys) and Se-methylselenocysteine (MeSeCys), in addition to the level
15 with most of this Se being in the form of Se-methylselenocysteine (MeSeCys).
16 n trichomes was present in the organic forms methylselenocysteine (MeSeCys; 53%) and gamma-glutamyl-M
17                Until recently, the use of Se-methylselenocysteine (MSC) as selective modulator of the
18                                              Methylselenocysteine (MSC) is an organic selenium compou
19 at GGMSC serves primarily as a carrier of Se-methylselenocysteine (MSC), which has been demonstrated
20 ion meals ( approximately 66% gamma-glutamyl-methylselenocysteine, providing the equivalent of 50 mic
21  Selenite (se(IV)), selenocysteine (SeC), Se-methylselenocysteine (SeMC) and selenomethionine (SeM).
22  vary in their anticarcinogenic efficacy, Se-methylselenocysteine (SeMSC) has been demonstrated to be
23 ng 30 ppb Se-methionine (SeMet) and 5 ppb Se-methylselenocysteine (SeMSC) with unselenized yeast extr
24 n the accumulation of anticancer compound Se-methylselenocysteine (SeMSCys) and glucosinolates in Bra
25 mals have an ample capacity to metabolize Se-methylselenocysteine systemically.
26 ic plants accumulated more Se in the form of methylselenocysteine than the wild type.
27 lerant moth and its parasite both accumulate methylselenocysteine, the same form found in the hyperac
28 te a monomethylated selenium species from Se-methylselenocysteine via the beta-lyase enzyme.
29                                       Seleno-methylselenocysteine was determined with values ranging
30 eactivity of the iranium ion derived from Se-methylselenocysteine was investigated and shown to react
31 etry, mainly accumulated the free amino acid methylselenocysteine, while S. albescens accumulated mai
32 d that represents a simplified version of Se-methylselenocysteine without the amino acid moiety, ther
33                                Therefore, Se-methylselenocysteine would be expected to behave like me